Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DI CHIRO, G.
Right arrow Articles by BLEYER, W. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DI CHIRO, G.
Right arrow Articles by BLEYER, W. A.
NEUROLOGY 1976;26:1
© 1976 American Academy of Neurology

Spinal descent of cerebrospinal fluid in man

GIOVANNI DI CHIRO, M.D., MARY K. HAMMOCK, M.D. and W. ARCHIE BLEYER, M.D.

From the Section on Neuroradiology, National Institutes of Health (Drs. Di Chiro and Hammock), and the Laboratory of Chemical Pharmacology, National Cancer Institute (Dr. Bleyer), Bethesda, Maryland.

The descent of radiopharmaceuticals injected within the right lateral ventricle toward and into the spinal subarachnoidal spaces has been followed by scintiphotographic techniques and by computerized flow analysis in a group of "normal" patients. A substantial and rapid downward progression of the albumin-tagged tracer has been observed. This progression is faster than the subarachnoidal ascent toward the convexity of the brain.

Requests for reprints should be addressed to Dr. Di Chiro, Section on Neuroradiology, National Institutes of Health, Bldg. 10, Room 2D13, Bethesda, MD 20014.

Received for publication July 13, 1975.




This article has been cited by other articles:


Home page
Am J Health Syst PharmHome page
V. L. Ghafoor, M. Epshteyn, G. H. Carlson, D. M. Terhaar, O. Charry, and P. K. Phelps
Intrathecal drug therapy for long-term pain management
Am. J. Health Syst. Pharm., December 1, 2007; 64(23): 2447 - 2461.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. M. Zeitzer, C. L. Buckmaster, D. M. Lyons, and E. Mignot
Increasing length of wakefulness and modulation of hypocretin-1 in the wake-consolidated squirrel monkey
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2007; 293(4): R1736 - R1742.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Edsbagge, M. Tisell, L. Jacobsson, and C. Wikkelso
Spinal CSF absorption in healthy individuals
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2004; 287(6): R1450 - R1455.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
J. M. Zeitzer, C. L. Buckmaster, D. M. Lyons, and E. Mignot
Locomotor-dependent and -independent components to hypocretin-1 (orexin A) regulation in sleep-wake consolidating monkeys
J. Physiol., June 15, 2004; 557(3): 1045 - 1053.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. M. Zeitzer, C. L. Buckmaster, K. J. Parker, C. M. Hauck, D. M. Lyons, and E. Mignot
Circadian and Homeostatic Regulation of Hypocretin in a Primate Model: Implications for the Consolidation of Wakefulness
J. Neurosci., April 15, 2003; 23(8): 3555 - 3560.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
S. Barz, T. Hummel, E. Pauli, M. Majer, C. J. G. Lang, and G. Kobal
Chemosensory event-related potentials in response to trigeminal and olfactory stimulation in idiopathic Parkinson's disease
Neurology, November 1, 1997; 49(5): 1424 - 1431.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. Lazzarini, K. O. Schwarz, S. Jiang, E. S. Stenroos, T. Lehner, and W. G. Johnson
Pelizaeus-Merzbacher-like disease: Exclusion of the proteolipid protein locus and documentation of a new locus on Xq
Neurology, September 1, 1997; 49(3): 824 - 832.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
G. Schlaug, C. Antke, H. Holthausen, S. Arnold, A. Ebner, I. Tuxhorn, L. Jancke, H. Luders, O. W. Witte, and R. J. Seitz
Ictal motor signs and interictal regional cerebral hypometabolism
Neurology, August 1, 1997; 49(2): 341 - 350.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
D. S. Younger, B. B. Worrall, and A. S. Penn
Myasthenia gravis: Historical perspective and overview
Neurology, April 1, 1997; 48(Suppl_5): 1S - 7S.
[Full Text] [PDF]


Home page
NeurologyHome page
H. J. Kaminski, J. I. Suarez, and R. L. Ruff
Neuromuscular junction physiology in myasthenia gravis: Isoforms of the acetylcholine receptor in extraocular muscle and the contribution of sodium channels to the safety factor
Neurology, April 1, 1997; 48(Suppl_5): 8S - 17S.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
D. B. Sanders, P. Ian Andrews, J. F. Howard Jr., MD, and J. M. Massey
Seronegative myasthenia gravis
Neurology, April 1, 1997; 48(Suppl_5): 40S - 45S.
[Full Text] [PDF]


Home page
NeurologyHome page
E. Gutling, S. Isenmann, and W. Wichmann
Electrophysiology in the locked-in-syndrome
Neurology, April 1, 1996; 46(4): 1092 - 1101.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
M. C. Chamberlain
Topical Review: A Review of Leptomeningeal Metastases in Pediatrics
J Child Neurol, May 1, 1995; 10(3): 191 - 199.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1976 by AAN Enterprises, Inc.